Chemical Structure (Chlordiazepoxide 01)
Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 75826-134
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 75826-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Winder Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Chlordiazepoxide 02)
Principal Display Panel (100 Capsule Bottle)
This is a description of Chlordiazepoxide HCI and Clidinium Bromide Capsules, USP, with each capsule containing 5 mg chlordiazepoxide HCl and 2.5 mg clidinium bromide. The usual adult dosage is one or two capsules 3 or 4 times a day before meals and at bedtime. The medication guide should be dispensed separately to each patient. It is advised to keep it out of the reach of children and store it between 20° to 25°C (68° to 77°F). The medication is manufactured by Winder Laboratories LLC in Winder, Georgia.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
